about
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activityThrombotic microangiopathy as an initial manifestation in HIV patients.Characterization of antiphospholipid antibodies in chronic hepatitis B infection.Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature review.HIV-Associated Venous ThromboembolismPathophysiology of the antiphospholipid antibody syndrome.Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal?The environment and antiphospholipid syndrome.Venous thromboembolism in patients with HIV/AIDS: a case-control studyStroke in sickle cell anemia: alternative etiologies.Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection.Review: Viral infections and mechanisms of thrombosis and bleeding.Anti-β2-glycoprotein I antibodies.The antiphospholipid syndrome: from pathophysiology to treatment.Anti-phospholipid Antibodies and Smoking: An Overview.Kaleidoscope of autoimmune diseases in HIV infection.Kidney disease in primary anti-phospholipid antibody syndrome.Human Parvoviruses.Herpes zoster infection associated with acute coronary syndrome: a population-based retrospective cohort study.Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.Bilateral cavo-ilio-femoral thrombosis in an adolescent with transient anti-phospholipid antibodies and factor V heterozygous mutation: a case report.Cytomegalovirus colitis associated with arterial thromboembolism in an immunocompetent elderly man.Anti-cardiolipin antibodies in sera from patients with periodontitis.Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection.Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis.Serum anticardiolipin concentrations in patients with chronic periodontitis following scaling and root planing.Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series.Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.Antiphospholipid antibodies in Brazilian hepatitis C virus carriers.Venous thromboembolism related to cytomegalovirus infection: A case report and literature review.Diagnosis and management of the antiphospholipid syndrome.Acute childhood hemiplegia associated with chickenpox and elevated anticardiolipin antibody.The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia.The increase of blood anticardiolipin antibody depends on the underlying etiology in cerebral ischemia.A patient with Hodgkin's lymphoma, antiphospholipid syndrome and severe mitral insufficiency.Transient presence of lupus anticoagulant associated with mycoplasma pneumonia.
P2860
Q28730532-16506898-D0A9-4C6B-B0C0-BC213C064554Q33433733-267D0614-43FE-4A34-9162-3532B024EAC8Q34729294-EA100438-99EB-47A4-8D34-CE85DB041B45Q34761674-790BA7A7-2580-4802-AED7-EBA168CA8EA4Q35153652-A2DF9C1B-F2F4-4EC1-BC11-ED07840123E1Q35309024-69BD1AE8-E74E-4EA6-B26C-1832544EF317Q35553410-E85189DB-0539-4408-8E59-2D1B6380283DQ35595386-C073D8CD-D6BF-4148-A413-88B12BF2B503Q35777683-FB582D8E-D795-4E73-95DB-177B8085AC2AQ36326309-EDB080A8-10D0-4647-A24D-2ABB551D95FEQ36677026-B1E7AB02-B440-4926-96D9-E8CF33FD249CQ37003352-7A6F09DE-B9EB-496E-B5F7-BC8AA8D9ED0BQ37340140-29FFD829-E2CA-4CA7-9F70-E08D4E8AF29BQ37813128-CF7830D9-48C7-488D-97FC-BBF9EC1F9531Q38038832-6DCE5BDD-D2BD-4922-AC8C-E89A5C25EE10Q38108396-3CBA5E8F-6C78-4B83-8EE6-AFAD164B35B5Q38873953-F8790529-0388-4858-B161-9FDEC9022DF6Q38885685-B6585097-596B-47ED-845A-63E15676E00AQ38932786-B456AF2E-2C72-481A-92F5-8E5E0FDE75FAQ38934375-9F3C05E0-E0BE-4F1C-8AE7-F13794241650Q38996997-E0804F00-68E0-44A7-90F0-EE48E60BCE68Q40159091-B534E4BE-C1E9-44E6-8D6D-5884CBB49C58Q42247741-79223E1C-F4F7-4245-897F-9951DA327D7DQ42263453-AF984B7E-9ADC-40A2-8259-A5CB4C757CCEQ42596364-3F8189B8-D122-426B-899D-5755A81BD9F8Q43852096-1F664145-48AF-4364-9E9C-7CB2EBA1A8D0Q44898311-3BF6D0AE-5179-4610-914C-4D22F17E512EQ44910504-A4075649-A91E-4394-BF66-4C2DB22DF117Q44927548-8FBB300E-87C8-4D1A-A069-02652F25A7D9Q44989597-F9B1381F-C9D1-484F-B790-5E1777427285Q45108757-40090848-0041-49AC-9C03-A4A4D8994E42Q45383876-EFA8DC5C-8C63-4DB4-A113-8EE40B8FACDDQ45394364-33364948-2CF2-4EF4-ADE6-6C70BA85A98FQ47547102-E043BE09-5B67-4A91-AB5C-E5EE5DA2D405Q47982275-5FE854B2-D8A1-4352-BE85-358394478F4DQ48411911-5E28D331-2C84-4A54-9FEF-01CF3DA4FFADQ48668659-3FA570E5-C226-4D7C-B806-EC146E00AF48Q48933689-CCB78688-2100-4E7E-84F5-9B0A5F1E7AE1Q51777386-00D69584-F2C5-4B7E-9B41-F9E2D5E7E784Q53219726-88172FF8-E97B-414F-A793-B30D978DD329
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Viral infections and antiphospholipid antibodies.
@ast
Viral infections and antiphospholipid antibodies.
@en
Viral infections and antiphospholipid antibodies.
@nl
type
label
Viral infections and antiphospholipid antibodies.
@ast
Viral infections and antiphospholipid antibodies.
@en
Viral infections and antiphospholipid antibodies.
@nl
prefLabel
Viral infections and antiphospholipid antibodies.
@ast
Viral infections and antiphospholipid antibodies.
@en
Viral infections and antiphospholipid antibodies.
@nl
P356
P1476
Viral infections and antiphospholipid antibodies.
@en
P2093
Imad W Uthman
P304
P356
10.1053/SARH.2002.28303
P577
2002-02-01T00:00:00Z